Literature DB >> 18196942

Human growth and cardiovascular disease.

David J P Barker1.   

Abstract

Low birthweight is now known to be associated with increased rates of coronary heart disease (CHD) and the related disorders, stroke, hypertension and type 2 diabetes. Associations between low birthweight and later disease have been extensively replicated in studies in different countries. They extend across the normal range of birthweight and depend on lower birthweights in relation to the duration of gestation rather than the effects of premature birth. The associations are thought to be consequences of developmental plasticity, the phenomenon by which one genotype can give rise to a range of different physiological or morphological states in response to different environmental conditions during development. Recent observations have shown that impaired growth in infancy and rapid childhood weight gain exacerbate the effects of impaired prenatal growth. CHD and the disorders related to it arise through a series of interactions between environmental influences and the pathways of growth and development that precede them.

Entities:  

Mesh:

Year:  2008        PMID: 18196942     DOI: 10.1159/000113163

Source DB:  PubMed          Journal:  Nestle Nutr Workshop Ser Pediatr Program        ISSN: 1661-6677


  19 in total

Review 1.  Epigenetics and developmental programming of adult onset diseases.

Authors:  Lee O'Sullivan; Alexander N Combes; Karen M Moritz
Journal:  Pediatr Nephrol       Date:  2012-12       Impact factor: 3.714

2.  Parental rheumatoid arthritis and long-term child morbidity: a nationwide cohort study.

Authors:  Ane Lilleøre Rom; Chun Sen Wu; Jørn Olsen; Damini Jawaheer; Merete Lund Hetland; Bent Ottesen; Lina Steinrud Mørch
Journal:  Ann Rheum Dis       Date:  2015-12-23       Impact factor: 19.103

3.  Effect of maternal obesity on fetal and postnatal baboon (Papio species) early life phenotype.

Authors:  Cun Li; Susan Jenkins; McKenna M Considine; Laura A Cox; Kenneth G Gerow; Hillary F Huber; Peter W Nathanielsz
Journal:  J Med Primatol       Date:  2018-12-20       Impact factor: 0.667

4.  Executive summary: Evaluating the evidence base to support the inclusion of infants and children from birth to 24 mo of age in the Dietary Guidelines for Americans--"the B-24 Project".

Authors:  Daniel J Raiten; Ramkripa Raghavan; Alexandra Porter; Julie E Obbagy; Joanne M Spahn
Journal:  Am J Clin Nutr       Date:  2014-02-05       Impact factor: 7.045

5.  The association of gestational age and birth weight with blood pressure among children: a Chinese national study.

Authors:  Minyi Tan; Li Cai; Jun Ma; Jin Jing; Yinghua Ma; Yajun Chen
Journal:  J Hum Hypertens       Date:  2018-06-25       Impact factor: 3.012

6.  Social position and chronic conditions across the life span and risk of stroke: a life course epidemiological analysis of 22,847 American adults in ages over 50.

Authors:  Longjian Liu; Fuzhong Xue; Jixiang Ma; Marshal Ma; Yong Long; Craig J Newschaffer
Journal:  Int J Stroke       Date:  2012-12-11       Impact factor: 5.266

7.  Childhood air pollutant exposure and carotid artery intima-media thickness in young adults.

Authors:  Carrie V Breton; Xinhui Wang; Wendy J Mack; Kiros Berhane; Milena Lopez; Talat S Islam; Mei Feng; Fred Lurmann; Rob McConnell; Howard N Hodis; Nino Künzli; Ed Avol
Journal:  Circulation       Date:  2012-08-15       Impact factor: 29.690

Review 8.  How to manage hypertension in pregnancy effectively.

Authors:  Laura A Magee; Edgardo Abalos; Peter von Dadelszen; Baha Sibai; Tom Easterling; Steve Walkinshaw
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

Review 9.  Long-term consequences of disrupting adenosine signaling during embryonic development.

Authors:  Scott A Rivkees; Christopher C Wendler
Journal:  Mol Aspects Med       Date:  2017-02-13

Review 10.  The epigenetic lorax: gene-environment interactions in human health.

Authors:  Keith E Latham; Carmen Sapienza; Nora Engel
Journal:  Epigenomics       Date:  2012-08       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.